1. Home
  2. DRMA vs TGL Comparison

DRMA vs TGL Comparison

Compare DRMA & TGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRMA
  • TGL
  • Stock Information
  • Founded
  • DRMA 2014
  • TGL 2020
  • Country
  • DRMA United States
  • TGL United States
  • Employees
  • DRMA N/A
  • TGL N/A
  • Industry
  • DRMA Biotechnology: Pharmaceutical Preparations
  • TGL Retail: Computer Software & Peripheral Equipment
  • Sector
  • DRMA Health Care
  • TGL Technology
  • Exchange
  • DRMA Nasdaq
  • TGL Nasdaq
  • Market Cap
  • DRMA 2.2M
  • TGL 2.4M
  • IPO Year
  • DRMA 2021
  • TGL 2022
  • Fundamental
  • Price
  • DRMA $1.33
  • TGL $0.24
  • Analyst Decision
  • DRMA Strong Buy
  • TGL
  • Analyst Count
  • DRMA 1
  • TGL 0
  • Target Price
  • DRMA $6.00
  • TGL N/A
  • AVG Volume (30 Days)
  • DRMA 230.6K
  • TGL 34.8M
  • Earning Date
  • DRMA 11-13-2024
  • TGL 02-12-2025
  • Dividend Yield
  • DRMA N/A
  • TGL N/A
  • EPS Growth
  • DRMA N/A
  • TGL N/A
  • EPS
  • DRMA N/A
  • TGL N/A
  • Revenue
  • DRMA N/A
  • TGL $8,810,305.00
  • Revenue This Year
  • DRMA N/A
  • TGL N/A
  • Revenue Next Year
  • DRMA N/A
  • TGL N/A
  • P/E Ratio
  • DRMA N/A
  • TGL N/A
  • Revenue Growth
  • DRMA N/A
  • TGL N/A
  • 52 Week Low
  • DRMA $1.00
  • TGL $0.15
  • 52 Week High
  • DRMA $8.66
  • TGL $12.60
  • Technical
  • Relative Strength Index (RSI)
  • DRMA 51.81
  • TGL 49.22
  • Support Level
  • DRMA $1.30
  • TGL $0.18
  • Resistance Level
  • DRMA $1.48
  • TGL $0.78
  • Average True Range (ATR)
  • DRMA 0.12
  • TGL 0.07
  • MACD
  • DRMA 0.00
  • TGL 0.01
  • Stochastic Oscillator
  • DRMA 49.66
  • TGL 11.26

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. Its product is an internet application branded ZCITY app, that targets consumers by providing personalized deals based on consumers' purchase history, location and preferences.

Share on Social Networks: